52.43000 USD
0.24
0.46%
Last update Dec 15, 4:23 PM GMT
Main market
Day range
52.28000
53.59000
Previous close
52.67000
Open
53.59000
Access this stock data via API
Subscribe
Biomarin Pharmaceutical Inc.
52.43
0.24
0.46%

Statistics

Valuation metrics
Market cap
9.34B
Enterprise value
9.25B
Trailing P/E (ttm)
2.41
Forward P/E
PEG ratio
Price/Sales (ttm)
3.06
Price/Book (mrq)
1.65
Enterprise Value/Revenue
2.99
Enterprise Value/EBITDA
11.64
Overview
Shares outstanding
178.06M
Float
190.43M
Shares short
% Held by insiders
0.77%
% Held by institutions
98.00%
Average volume (10 days)
544
Average volume (90 days)
1.20K
Price summary
52-Week low
50.60
52-Week high
73.33
52-Week change
-29.56 -58.4%
Beta
0.30
50-Day moving average
90.32
200-Day moving average
89.61
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Dec 31, 2024
Profitability
Profit margin
16.82%
Operating margin
-6.02%
Operational effectiveness
Return on assets
6.15%
Return on equity
9.07%
Income statement
Revenue (ttm)
3.09B
Revenue per share (ttm)
16.17
Quarterly revenue growth (yoy)
4.10%
Gross profit (ttm)
2.52B
EBITDA
794.05M
Net income to common (ttm)
520.42M
Diluted EPS (ttm)
0.22
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
1.48B
Total cash per share (mrq)
7.69
Total debt (mrq)
604.24M
Total Debt/Equity (mrq)
9.98
Current ratio (mrq)
482.80%
Book value per share (mrq)
31.53
Cash flow
Cash flow statement
913.98M
Levered free cash flow (LFCF)
451.55M
Access /statistics data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 7 hours 55 minutes

08:34
00:00
08:00
16:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:15 - 08:00
Main market
08:00 - 16:30
Post-market
16:30 - 17:15
All times are displayed in the Europe/London timezone (GMT, UTC+00:00).